Institutional Ownership
Verrica Pharmaceuticals Inc
CUSIP 92511W207COM SHSVRCAQ1 2026
13D / 13G Filings
7
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
49.9%
Max % of class reported
Institutional Holders
36
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
7 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Armistice Capital, LLC | 13G/A | 5.0% | 439.7K | SEC |
| 2 | Jan 29, 2026 | Affinity Asset Advisors, LLC | 13G/A | 5.5% | 884.2K | SEC |
| 3 | Dec 30, 2025 | Caligan Partners LP | 13D/A | 10.0% | — | SEC |
| 4 | Dec 3, 2025 | Affinity Asset Advisors, LLC | 13G | 5.5% | 884.2K | SEC |
| 5 | Nov 28, 2025 | Paul B Manning | 13D/A | 49.9% | — | SEC |
| 6 | Nov 24, 2025 | Caligan Partners LP | 13D | 10.0% | — | SEC |
| 7 | Nov 14, 2025 | Armistice Capital, LLC | 13G/A | 6.8% | 639.2K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Caligan Partners LP | 923.9K | $4.89M |
| 2 | Affinity Asset Advisors, LLC | 707.3K | $3.74M |
| 3 | Cannell Capital LLC | 685.1K | $3.62M |
| 4 | Armistice Capital, LLC | 518.2K | $2.74M |
| 5 | Velan Capital Investment Management LP | 471.6K | $2.49M |
| 6 | Boothbay Fund Management, LLC | 280.7K | $1.49M |
| 7 | Dafna Capital Management LLC | 153.7K | $813.1K |
| 8 | Marshall Wace, LLP | 140.5K | $743.2K |
| 9 | Geode Capital Management, LLC | 138.9K | $735.0K |
| 10 | Stonepine Capital Management, LLC | 99.7K | $527.6K |